Pangaea Oncology, in collaboration with Dexeus University Hospital, conducts a wide range of clinical trials aimed at improving cancer treatment options. These trials include investigator-initiated trials, cooperative academic studies, and industry-sponsored trials. The organization focuses on enrolling patients in high-impact trials, particularly those with uncommon and deadly cancers. Pangaea Oncology has made significant contributions to the field, with over 100 publications in high-impact journals and the approval of novel drugs in oncology. The organization also prioritizes patient access to drugs, especially for those with limited financial resources. They have developed studies for patients who are typically excluded from clinical trials, such as those with viral infections. Pangaea Oncology's laboratory utilizes advanced methodologies, including next-generation sequencing and liquid biopsy testing, to analyze cancer samples. The organization collaborates with leading institutions and scientific organizations worldwide and values diversity and inclusivity in its staff and patient advocacy efforts. [Extracted from the article]